Merck, Amgen Invest In Medical Video Game Developer Akili
Executive Summary
Akili Interactive Labs Inc., a digital medicine company, has secured an additional $11.9m funding via series B financing with backing from Merck KGaA and Amgen Inc.
You may also be interested in...
Pharma Gets In The Game With Akili’s ‘Digital Medicine’ For Cognitive Disorders
What if a video game could treat a player's cognitive disorder? It may sound like a sci-fi fantasy, but a company developing such a platform has recently raised $30.5m in equity investments to take the product through US FDA clearance and potential 2017 launch.
Text Mining And Machine Reading: The Answer To Pharma's R&D Data Mountain?
How to make the most of the wealth of raw data in pharmaceutical R&D is an increasing challenge for the industry. The digital revolution is already having an impact in areas like clinical trials, and pharma is also starting to embrace new technologies in drug discovery.
Adherence Issues Add Weight To Digital Trials Push
Technology advancement has brought a wave of change in healthcare, with an increasing number of key pharma players now recognizing the potential of digital – particularly in clinical trials.